article thumbnail

The FDA Releases New Draft Guidance on Considering Health Care Disparities When Reviewing Proposed Devices

C&M Health Law

Food and Drug Administration (FDA) released a draft guidance that, if finalized, will update the agency’s 2018 guidance on its Breakthrough Devices Program (the “Program”). If this latest draft guidance is finalized after a period of public comment, the agency will incorporate the proposed language into the 2018 guidance.

FDA 52
article thumbnail

How Will New FDA Hearing Aid Regulations Impact Health Plans?

HIT Consultant

First, let’s examine the new regulatory framework the FDA established. Health plans should be on the alert for potential pitfalls arising from the new regulations. Health plans can design hearing benefits that can mitigate this potential issue while maximizing member satisfaction at the same time. Introducing OTC hearing aids.

FDA 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Tobacco Issues Awaiting Robert Califf at the FDA

Bill of Health

Food and Drug Administration (FDA), bringing a drawn out and contentious process to a close. Califf will be the second-ever FDA Commissioner to serve non-consecutive terms, and the first to have been confirmed by the Senate on two separate occasions. Banning Menthol Cigarettes.

FDA 274
article thumbnail

CareCloud CEO predicts what's around the corner for telehealth

Healthcare IT News - Telehealth

What's less certain, however, is what that utilization will look like in the future, particularly as the end of the public health emergency looms. We launched our first fully integrated telehealth solution in the 2018-2019 timeframe. First of all, we should think about the public health emergency.

COVID-19 162
article thumbnail

CBD 101: Just the Facts

NY Health Law

In December 2018, Congress passed the Farm Bill which legalized hemp – defined in the Farm Bill as cannabis and cannabis derivatives with very low concentrations – less than 0.3 The FDA is struggling to determine how to regulate CBD. percent – of THC. We will continue to provide updates as new information comes to light.

FDA 52
article thumbnail

Better Health Care Tests, Faster

Healthcare IT Today

They also plan to offer APIs to labs and public health organizations, delivering test results securely through an app along with advice about how to handle the risk. Also, ixlayer utilizes only FDA-approved sample collection devices following best practice standards, everything in HIPAA compliant environment.

COVID-19 103
article thumbnail

Heart-Love – Omron’s Holy Grail of Blood Pressure Tracking on the Wrist

Health Populi

Omron is submitting the HeartGuide watch for FDA review this year and once cleared, the device will be the first blood pressure monitor that accurately reads BP right from the wrist. Omron seeks to jump that hurdle through FDA clearance.

FDA 81